BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23484887)

  • 1. Medical therapy as the primary modality for the management of chronic rhinosinusitis.
    Ocampo CJ; Peters AT
    Allergy Asthma Proc; 2013; 34(2):132-7. PubMed ID: 23484887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations.
    Li N; Peters AT
    Allergy Asthma Proc; 2015; 36(5):339-43. PubMed ID: 26314815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis.
    Howard BE; Lal D
    Curr Allergy Asthma Rep; 2013 Apr; 13(2):236-43. PubMed ID: 23225105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of topical nasal therapies in the management of chronic rhinosinusitis.
    Wei CC; Adappa ND; Cohen NA
    Laryngoscope; 2013 Oct; 123(10):2347-59. PubMed ID: 23553558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey on chronic rhinosinusitis: opinions from experts of 50 countries.
    Passali D; Cingi C; Cambi J; Passali F; Muluk NB; Bellussi ML
    Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2097-109. PubMed ID: 26742909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis.
    Gillespie MB; Osguthorpe JD
    Curr Allergy Asthma Rep; 2004 Nov; 4(6):478-85. PubMed ID: 15462715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions.
    Ranford D; Hopkins C
    Expert Opin Drug Saf; 2021 Oct; 20(10):1177-1189. PubMed ID: 33957840
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical practice guideline (update): adult sinusitis.
    Rosenfeld RM; Piccirillo JF; Chandrasekhar SS; Brook I; Ashok Kumar K; Kramper M; Orlandi RR; Palmer JN; Patel ZM; Peters A; Walsh SA; Corrigan MD
    Otolaryngol Head Neck Surg; 2015 Apr; 152(2 Suppl):S1-S39. PubMed ID: 25832968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
    Jandus P; Harr T; Soyka MB; Landis BN
    Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 6: Nasal polyps.
    Settipane RA; Peters AT; Chiu AG
    Am J Rhinol Allergy; 2013; 27 Suppl 1():S20-5. PubMed ID: 23711034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobials and chronic rhinosinusitis with or without polyposis in adults: an evidenced-based review with recommendations.
    Soler ZM; Oyer SL; Kern RC; Senior BA; Kountakis SE; Marple BF; Smith TL
    Int Forum Allergy Rhinol; 2013 Jan; 3(1):31-47. PubMed ID: 22736403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [International therapeutic guidelines for rhinosinusitis give good guidance. Lessens the pressure on antibiotics in Sweden].
    Holmström M
    Lakartidningen; 2008 Nov 5-11; 105(45):3202, 3204-6. PubMed ID: 19062612
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical triamcinolone acetonide/carboxymethylcellulose foam for acute exacerbations of chronic rhinosinusitis/nasal polyposis.
    Chaudhry AL; Chaaban MR; Ranganath NK; Woodworth BA
    Am J Rhinol Allergy; 2014; 28(4):341-4. PubMed ID: 24819563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical therapy in the management of chronic rhinosinusitis.
    Huang A; Govindaraj S
    Curr Opin Otolaryngol Head Neck Surg; 2013 Feb; 21(1):31-8. PubMed ID: 23277167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy.
    Ragab SM; Lund VJ; Saleh HA; Scadding G
    Allergy; 2006 Jun; 61(6):717-24. PubMed ID: 16677241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: Risks and benefits.
    Poetker DM
    Am J Rhinol Allergy; 2015; 29(5):339-42. PubMed ID: 26358344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy.
    Dessouky O; Hopkins C
    Curr Allergy Asthma Rep; 2015 Nov; 15(11):66. PubMed ID: 26411803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
    Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
    Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.